Tatsuya Maekawa Selected Research

Tatsuya Maekawa Research Topics

3	Fibrosis (Cirrhosis) 07/2022 - 06/2018
3	Body Weight (Weight, Body) 01/2021 - 08/2006
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	Dermatitis 08/2006 - 10/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Non-alcoholic Fatty Liver Disease 07/2022
1	Hypertrophy 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 04/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Inflammation (Inflammations) 06/2018
1	Hyperglycemia 06/2018
1	Hyperlipidemias (Hyperlipidemia) 06/2018
1	Diabetes Mellitus 01/2018
1	Obesity 11/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2017
1	Atopic Dermatitis (Atopic Eczema) 08/2006
1	Weight Loss (Weight Reduction) 08/2006
1	Pruritus (Itching) 10/2002

2	SaltsIBA 01/2023 - 01/2021
2	LipidsIBA 07/2022 - 06/2018
1	SodiumIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	Estrogens (Estrogen)FDA Link 07/2022
1	Histones (Histone)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	NitrogenIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Sodium Chloride FDA LinkGeneric 01/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021
1	CreatinineIBA 01/2021
1	Pioglitazone (Actos)FDA Link 06/2018
1	CholesterolIBA 06/2018
1	microsomal triglyceride transfer proteinIBA 06/2018
1	Metformin (Glucophage)FDA LinkGeneric 06/2018
1	Messenger RNA (mRNA)IBA 06/2018
1	MelatoninIBA 01/2018
1	NAD (NADH)IBA 11/2017
1	Betamethasone (Celestone)FDA Link 08/2006
1	CB2 Cannabinoid ReceptorIBA 08/2006
1	JTE 907IBA 08/2006
1	CannabinoidsIBA 08/2006
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2006
1	Naltrexone (ReVia)FDA LinkGeneric 10/2002
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2002

1	Ovariectomy (Oophorectomy) 07/2022